Literature DB >> 5784616

Biologically active cortisol in plasma of oestrogen-treated and normal subjects.

C W Burke.   

Abstract

Biologically active (non-protein-bound) cortisol levels in the plasma of 13 women taking oral contraceptives and of 67 normal subjects were compared, using a new method-steady-state gel filtration. Both total and unbound cortisol levels in the 67 normal subjects showed a skew distribution, which was roughly log-normal.Unbound cortisol levels in 11 of the oestrogen-treated women were in the normal range, but the median value was significantly increased in this group. Total plasma cortisol levels in the oestrogen-treated group were, as expected, increased threefold, and all were outside the normal range.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5784616      PMCID: PMC1983710          DOI: 10.1136/bmj.2.5660.798

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens.

Authors:  A A SANDBERG; W R SLAUNWHITE
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Significance of the concentration of nonprotein-bound plasma cortisol in normal subjects, Cushing's syndrome, pregnancy, and during estrogen therapy.

Authors:  R P DOE; H H ZINNEMAN; E B FLINK; R A ULSTROM
Journal:  J Clin Endocrinol Metab       Date:  1960-11       Impact factor: 5.958

3.  The reliability of some adrenal function tests.

Authors:  C L COPE; E G BLACK
Journal:  Br Med J       Date:  1959-11-28

4.  The effect of estrogen administration on the metabolism and protein binding of hydrocortisone.

Authors:  I H MILLS; H P SCHEDL; P S CHEN; F C BARTTER
Journal:  J Clin Endocrinol Metab       Date:  1960-04       Impact factor: 5.958

5.  Estrogen dosage effects on serum proteins: a longitudinal study.

Authors:  R P Doe; G T Mellinger; W R Swaim; U S Seal
Journal:  J Clin Endocrinol       Date:  1967-08

6.  The secretion and metabolism of cortisol and aldosterone in normal and in steroid-treated women.

Authors:  D S LAYNE; C J MEYER; P S VAISHWANAR; G PINCUS
Journal:  J Clin Endocrinol Metab       Date:  1962-02       Impact factor: 5.958

7.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

8.  Accurate measurement of steroid-protein binding by steady-state gel filtration.

Authors:  C W Burke
Journal:  Biochim Biophys Acta       Date:  1969-03-04

9.  In vitro physiological activity of protein-bound and unbound cortisol.

Authors:  N Matsui; J E Plager
Journal:  Endocrinology       Date:  1966-06       Impact factor: 4.736

10.  Cortisol binding to plasma proteins in man in health, stress and at death.

Authors:  D Murray
Journal:  J Endocrinol       Date:  1967-12       Impact factor: 4.286

View more
  11 in total

Review 1.  Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.

Authors:  B Andersson
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

2.  Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.

Authors:  A Breckenridge; C W Burke; D S Davies; M L Orme
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

3.  Increased exposure of tissues to cortisol in late pregnancy.

Authors:  C W Burke; F Roulet
Journal:  Br Med J       Date:  1970-03-14

4.  [Plasma phosphatides and oral contraceptives].

Authors:  P Jipp
Journal:  Klin Wochenschr       Date:  1970-12-01

5.  Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Authors:  P J Meffin; L M Wing; B C Sallustio; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

6.  High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.

Authors:  T C Friedman; D E Ghods; H K Shahinian; L Zachery; N Shayesteh; S Seasholtz; E Zuckerbraun; M L Lee; I E McCutcheon
Journal:  Horm Metab Res       Date:  2010-08-27       Impact factor: 2.936

Review 7.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

8.  Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.

Authors:  M E Pall; M C Lao; S S Patel; M L Lee; D E Ghods; D W Chandler; T C Friedman
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

Review 9.  Adrenal disorders in pregnancy.

Authors:  Silvia Monticone; Richard J Auchus; William E Rainey
Journal:  Nat Rev Endocrinol       Date:  2012-09-11       Impact factor: 43.330

10.  The choice of estrogen preparations in the treatment of prostatic cancer.

Authors:  A Morales; B Pujari
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.